Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trialAxel Bauer, Uwe Dorwarth, Michael Schreinlechner et al.|The Lancet Respiratory Medicine|2021Cited by 104
Residual Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair: Insights Into the EuroTR RegistryLukas Stolz, Karl‐Patrik Kresoja, Jennifer von Stein et al.|European Journal of Heart Failure|2024Cited by 57
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligenceJulius Keyl, Jens Kleesiek, Nikolaos E. Bechrakis et al.|Nature Cancer|2025Cited by 48
Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO miceGuang Yang, Johannes Stegbauer, Geoffrey Istas et al.|Pflügers Archiv - European Journal of Physiology|2018Cited by 27
Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotectionJulia Pohl, Tienush Rassaf|Thrombosis and Haemostasis|2015Cited by 24